Medifast, Inc. MED | NYSE
$11.43
-$0.09 | -0.78%
SIGNAL:
|2026-09-29
|F&G 42
|RSI 43.5
|2026-09-29
|F&G 42
|RSI 43.5
Company Overview:
Market Cap:
$127.80M
Trailing PE:
N/A
FWD PE:
—
Payout Ratio (TTM):
—
52-Week Range:
$9.22 - $14.15
10 Year MED Performance Metrics:
Total Return (with DRIP):
-61.4% (-9.09% CAGR)
Total Return (no DRIP):
6.9% (0.67% CAGR)
Share Price:
-70.0% (-11.34% CAGR)
Yield on Cost (with DRIP):
22.27%
Total Invested:
$10,000
Total Value (with DRIP):
$3,857
Total Return $ (with DRIP):
-$6,143
Dividend Increase:
415.6% (26.45% CAGR)
Dividend Yield (FWD):
57.74% ($6.60)
MED 10-yr Total Return ($10K invested)
1M
3M
6M
YTD
1Y
3Y
5Y
10Y
MED Share Price
1M
3M
6M
YTD
1Y
3Y
5Y
10Y
All
MED Price CAGR:1Y: -15.77%2Y: -22.88%5Y: -43.24%10Y: -11.27%
MED Dividend Charts
MED Dividend CAGR:1Y: 0.61%2Y: 7.79%5Y: 28.01%10Y: 27.62%
MED Dividend Payout Ratio CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
MED Dividend to FCF Ratio CAGR:1Y: 0.00%2Y: 1,681.19%5Y: -38.13%10Y: -8.76%
Unlock All Reports & Research Dividend Stocks like a BOSS!
Save 25% with annual plan (3 Months Free)
Save 25% with annual plan (3 Months Free)
PRO
$19/mo
$11.40/mo
7-day free trial
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
You save $7.60 (40%)
Most Popular
PREMIUM
$32/mo
$19.20/mo
7-day free trial
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
You save $12.80 (40%)
ULTRA
$64/mo
$38.40/mo
7-day free trial
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
You save $25.60 (40%)
PRO
$171 ($14.25/mo)
$102.60/yr ($8.55/mo)
7-day free trial
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
You save $125.40 (55%)
Most Popular
PREMIUM
$288 ($24/mo)
$172.80/yr ($14.40/mo)
7-day free trial
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
You save $211.20 (55%)
ULTRA
$576 ($48/mo)
$345.60/yr ($28.80/mo)
7-day free trial
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
You save $422.40 (55%)
MED Fundamentals: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:
MED Revenue CAGR:1Y: -27.64%2Y: -32.68%5Y: -27.98%10Y: 0.71%
MED EPS CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
🔓 See the full chart40% off right now · 7-day free trial
MED Net Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
🔓 See the full chart40% off right now · 7-day free trial
MED EBITDA CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
🔓 See the full chart40% off right now · 7-day free trial
MED Free Cash Flow CAGR:1Y: 0.00%2Y: -74.43%5Y: -44.05%10Y: -23.34%
🔓 See the full chart40% off right now · 7-day free trial
MED Free Cash Flow / Share CAGR:1Y: 0.00%2Y: -74.65%5Y: -43.44%10Y: -22.89%
🔓 See the full chart40% off right now · 7-day free trial
MED Operating Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
🔓 See the full chart40% off right now · 7-day free trial
MED Gross Profit CAGR:1Y: -30.33%2Y: -34.23%5Y: -28.89%10Y: 0.03%
🔓 See the full chart40% off right now · 7-day free trial
MED Shares Outstanding CAGR:1Y: 0.68%2Y: 0.90%5Y: -1.25%10Y: -0.65%
🔓 See the full chart40% off right now · 7-day free trial
MED Share Buybacks CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
🔓 See the full chart40% off right now · 7-day free trial
MED Stock-Based Comp CAGR:1Y: -30.80%2Y: -13.93%5Y: -3.26%10Y: 10.53%
🔓 See the full chart40% off right now · 7-day free trial
MED Expenses CAGR:1Y: -29.68%2Y: -29.29%5Y: -33.76%10Y: 3.76%
🔓 See the full chart40% off right now · 7-day free trial
🔓 See the full chart40% off right now · 7-day free trial
🔓 See the full chart40% off right now · 7-day free trial
🔓 See the full chart40% off right now · 7-day free trial
🔓 See the full chart40% off right now · 7-day free trial
🔓 See the full chart40% off right now · 7-day free trial
🔓 See the full chart40% off right now · 7-day free trial
MED Revenue CAGR:1Y: -27.64%2Y: -32.68%5Y: -27.98%10Y: 0.71%
Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:
🔓 See the full chart40% off right now · 7-day free trial
MED Actual Revenue CAGR:1Y: -27.64%2Y: -32.68%5Y: -27.98%10Y: 0.71%
🔓 See the full chart40% off right now · 7-day free trial
MED Actual EPS CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
🔓 See the full chart40% off right now · 7-day free trial
MED Actual Net Income CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
🔓 See the full chart40% off right now · 7-day free trial
MED Actual EBITDA CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
Ratios, Profit Margins & Return on Capital:
🔓 See the full chart40% off right now · 7-day free trial
MED Net Profit Margin CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
🔓 See the full chart40% off right now · 7-day free trial
MED Gross Profit Margin CAGR:1Y: -3.73%2Y: -2.30%5Y: -1.27%10Y: -0.68%
🔓 See the full chart40% off right now · 7-day free trial
MED Price to Earnings CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
🔓 See the full chart40% off right now · 7-day free trial
MED Price To Sales Ratio CAGR:1Y: 5.72%2Y: 6.47%5Y: -28.77%10Y: -11.95%
🔓 See the full chart40% off right now · 7-day free trial
MED Return on Capital Employed CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
🔓 See the full chart40% off right now · 7-day free trial
MED Return on Invested Capital CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%
MED Dividends Info:
Annual Dividend:
$6.6
Forward Yield:
57.74%
Ex-Dividend Date:
2023-09-18
Lifetime Dividends / Share:
$30.04
MED Dividend History: Dates, Payments & Yield list
Below is a schedule of all MED dividend payments, ex-dates, share price on the day of the payment as well as the annualized yield & forward yield
| Ex-Date | Payment Date | Amount | Yield | Forward Yield | Price on Ex-Date |
|---|---|---|---|---|---|
| 09/18/2023 | 11/07/2023 | $1.650 | 8.21% | 9.58% | $68.89 |
| 06/26/2023 | 08/08/2023 | $1.650 | 7.33% | 7.38% | $89.42 |
| 03/27/2023 | 05/09/2023 | $1.650 | 6.66% | 7.54% | $87.50 |
| 12/19/2022 | 02/07/2023 | $1.640 | 5.74% | 5.71% | $114.97 |
| 09/19/2022 | 11/08/2022 | $1.640 | 5.59% | 5.99% | $109.43 |
| 06/27/2022 | 08/08/2022 | $1.640 | 3.47% | 4.81% | $136.49 |
| 03/28/2022 | 05/09/2022 | $1.640 | 3.84% | 3.63% | $180.90 |
| 12/20/2021 | 02/08/2022 | $1.420 | 2.62% | 2.9% | $196.12 |
| 09/20/2021 | 11/08/2021 | $1.420 | 2.62% | 2.58% | $219.84 |
| 06/21/2021 | 08/06/2021 | $1.420 | 2.14% | 2.19% | $259.55 |
| 03/29/2021 | 05/06/2021 | $1.420 | 2.74% | 2.13% | $267.03 |
| 12/21/2020 | 02/05/2021 | $1.130 | 2.32% | 1.8% | $251.01 |
| 09/21/2020 | 11/06/2020 | $1.130 | 2.63% | 2.61% | $173.48 |
| 06/29/2020 | 08/06/2020 | $1.130 | 3.31% | 2.75% | $164.44 |
| 03/30/2020 | 05/06/2020 | $1.130 | 7.07% | 5.19% | $87.10 |
| 12/26/2019 | 02/06/2020 | $1.130 | 4.17% | 4.44% | $101.83 |
| 09/26/2019 | 11/07/2019 | $0.750 | 3% | 2.94% | $102.00 |
| 06/27/2019 | 08/07/2019 | $0.750 | 2.33% | 2.89% | $103.95 |
| 03/28/2019 | 05/07/2019 | $0.750 | 2.35% | 2.07% | $145.21 |
| 12/20/2018 | 02/07/2019 | $0.750 | 2.46% | 2.36% | $127.07 |
| 09/20/2018 | 11/08/2018 | $0.480 | 0.9% | 1.24% | $154.56 |
| 06/28/2018 | 08/08/2018 | $0.480 | 1.22% | 0.94% | $203.86 |
| 03/28/2018 | 05/08/2018 | $0.480 | 2.1% | 1.62% | $118.50 |
| 12/21/2017 | 02/08/2018 | $0.480 | 2.66% | 2.88% | $66.75 |
| 09/21/2017 | 11/09/2017 | $0.320 | 2.28% | 1.84% | $69.40 |
| 06/21/2017 | 08/09/2017 | $0.320 | 3.08% | 2.56% | $50.02 |
| 03/21/2017 | 05/09/2017 | $0.320 | 2.99% | 2.74% | $46.80 |
| 12/21/2016 | 02/09/2017 | $0.320 | 2.98% | 2.97% | $43.06 |
| 09/21/2016 | 11/10/2016 | $0.250 | 2.63% | 2.62% | $38.13 |
| 06/23/2016 | 08/10/2016 | $0.250 | 3.05% | 2.84% | $35.18 |
| 03/17/2016 | 05/10/2016 | $0.250 | 3.46% | 2.88% | $34.68 |
| 12/23/2015 | 02/10/2016 | $0.250 | 3.21% | 3.54% | $28.26 |
Projected Future Returns & Dividends for MED
Based on past 10-year performance, here are MED growth metrics:
Share price CAGR of -11.27%
Dividend CAGR of +27.61%
Using MED CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:
| MED (DRIP) | MED - No DRIP | |
|---|---|---|
| Current Price | $11.43 | $11.43 |
| Start Shares | 874.89 | 874.89 |
| Start Value | $10,000 | $10,000 |
| After 10 years: | ||
| Final Share Count | 1,000,000.00 | 874.89 |
| Dividends Payment | $2.87 | $2.87 |
| Annual Dividends | $11,483,965 | $10,047 |
| Yield on cost | 114,839.65% | 100.47% |
| Share Price | $3.46 | $3.46 |
| Total Dividends | $52,810,276 | $99,582 |
| Final Value | $3,457,129 | $102,607 |
Estimated Future Value + Dividends - MED
NOTE: Above numbers are our estimate based on MED's Dividend and Price CAGR over past 10 years.
These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.
We cannot guarantee that your actual returns will meet these estimates.
Get the best Dividend Stock Research Tools:
Save 25% with annual plan (3 Months Free)
Save 25% with annual plan (3 Months Free)
PRO
$19/mo
$11.40/mo
7-day free trial
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
You save $7.60 (40%)
Most Popular
PREMIUM
$32/mo
$19.20/mo
7-day free trial
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
You save $12.80 (40%)
ULTRA
$64/mo
$38.40/mo
7-day free trial
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
You save $25.60 (40%)
PRO
$171 ($14.25/mo)
$102.60/yr ($8.55/mo)
7-day free trial
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
You save $125.40 (55%)
Most Popular
PREMIUM
$288 ($24/mo)
$172.80/yr ($14.40/mo)
7-day free trial
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
You save $211.20 (55%)
ULTRA
$576 ($48/mo)
$345.60/yr ($28.80/mo)
7-day free trial
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
You save $422.40 (55%)
Company Info
Medifast, Inc. (MED) had its IPO on 1993-12-30, and is traded on NYSE stock exchange.
Medifast, Inc., through its various divisions, develops and provides a range of consumable health and nutritional items tailored for weight loss, weight management, and general wellness. These products are distributed across the United States and the Asia-Pacific region. Their extensive portfolio encompasses snack bars, savory bites, cereals, drinks, substantial meal choices, oatmeal, pancakes, puddings, soft serves, shakes, smoothies, baked goods, and soups. These offerings are marketed under proprietary brands like OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home. The company facilitates sales primarily through direct e-commerce transactions. Established in 1980, Medifast, Inc. maintains its corporate headquarters in Baltimore, Maryland.
MED website: https://medifastinc.com
Get Full Access to All Reports with DRIPCalc PRO
Save 25% with annual plan (3 Months Free)
Save 25% with annual plan (3 Months Free)
PRO
$19/mo
$11.40/mo
7-day free trial
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
You save $7.60 (40%)
Most Popular
PREMIUM
$32/mo
$19.20/mo
7-day free trial
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
You save $12.80 (40%)
ULTRA
$64/mo
$38.40/mo
7-day free trial
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
You save $25.60 (40%)
PRO
$171 ($14.25/mo)
$102.60/yr ($8.55/mo)
7-day free trial
- Unlimited Portfolio Tracker
- Portfolio - Lots/Sales/Dividends
- Portfolio Auto-DRIP
- Buy/Sell Signals Dashboard
- Stock Fundamentals
- Compare Stocks Side-by-Side
- Revenue & EPS Estimates
- DCF Valuation Modeling
You save $125.40 (55%)
Most Popular
PREMIUM
$288 ($24/mo)
$172.80/yr ($14.40/mo)
7-day free trial
- Everything in Pro
- YieldMax PNL Tracker
- YieldMax NAV Erosion Alerts
- YM ETFs Trend Signals
- 9/21 EMA Trend Signals
- Stocks Dashboard
You save $211.20 (55%)
ULTRA
$576 ($48/mo)
$345.60/yr ($28.80/mo)
7-day free trial
- Everything in Premium
- 15min & 1hr Intraday Signals
- Group & weekly ETF estimates
- YouTuber Mode
- Trades summary + CSV export
- Priority data & support
You save $422.40 (55%)
Loading signals…
DCF Model — MED
Value from:
🔒 Upgrade to unlock
The full DCF valuation — fair value, implied growth and the price path — is a paid feature.
Upgrade
Pay up to today
—
vs current price $11.43
—
Cash flow & implied price by year
FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.
EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.
Free cash flow today
—
grows for the next years
Then mature
—
every future dollar counted back to today
Pile of today-dollars
—
÷ shares
Implied price path
| Year | FCF | Implied price |
|---|
Sensitivity — fair value: growth ↓ × target return →
